Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2250 Suc-ala-ala-pro-glu-pna 606.6 C26H34N6O11
R2251 Boc-Ala-Ala-Phe-pNA 527.6 C26H33N5O7
R2252 Meosuc-aapm-pna 622.7 C27H38N6O9S
R2253 H-Ser-Gly-Gln-Tyr-Ala-Ser-Tyr-His-Cys-Trp-Cys-Trp-Arg-Asp-Pro-Gly-Arg-Ser-Gly-Gly-Ser-Lys-OH 2488.7 C107H150N34O32S2
R2254 Tak-683 1298.4 C64H83N17O13
R2255 Pz-128 1086.5 C55H99N13O9
R2256 Ciraparantag 512.7 C22H48N12O2
R2257 Ac-Phe-Arg-AMC HCl 557 C27H33ClN6O5
R2258 Gepon 1818 C74H132N26O27
R2259 Dstyslsstltlsk 1502.6 C64H107N15O26
R2260 Boc-DL-Leu-DL-Ser-DL-xiThr-DL-Arg-AMC 732.8 C34H52N8O10
R2261 Fmoc-Val-Cit-PAB 601.7 C33H39N5O6
R2262 (D-His2)-Leuprolide Trifluoroacetic Acid Salt 1209.4 C59H84N16O12
R2263 CID 91213358 762.9 C35H58N10O9
R2264 M2e, human 2624.8 C107H170N32O41S2
R2265 N-[(1S)-1-[[(E,1S)-3-(benzenesulfonyl)-1-phenethyl-allyl]carbamoyl]-3-methyl-butyl]morpholine-4-carboxamide 527.7 C28H37N3O5S
R2266 Epsilon-V1-2 844 C37H65N9O13
R2267 Tridecanedioic acid 244.33 C13H24O4
R2268 Ftisadtsk 969 C42H68N10O16
R2269 Leesggglvqpggsmk 1545.7 C64H108N18O24S